Monoclonal antibodies and nonpeptide antagonists to angiotensin II. Potential implications.
Author(s) -
Ben G. Zimmerman
Publication year - 1989
Publication title -
hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.986
H-Index - 265
eISSN - 1524-4563
pISSN - 0194-911X
DOI - 10.1161/01.hyp.14.5.498
Subject(s) - medicine , angiotensin ii , monoclonal antibody , renin–angiotensin system , antihypertensive drug , blood pressure , captopril , pharmacology , antibody , immunology
The introduction of agents capable of blocking the function of the renin-angiotensin system has had a profound impact on our knowledge of the physiology of the renin-angiotensin system and its role in various pathophysiological conditions, including hypertension
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom